Nicholas J.H. Warren

Inhibition of checkpoint kinase 1 following gemcitabine-mediated S phase arrest results in CDC7- and CDK2-dependent replication catastrophe

Nicholas J.H. Warren, Alan Eastman · Journal of Biological Chemistry · 2018 · 30 citations · Full text

Life Sciences, Cancer Biology, Oncology +17

How Did We Get a COVID-19 Vaccine in Less Than 1 Year?

E. John Wherry, Elizabeth M. Jaffee, Nicholas J.H. Warren et al. · Clinical Cancer Research · 2021 · 15 citations · Full text

Medicine, Immunology, Oncology +12

Comparison of the Intrinsic Dynamics of Aminoacyl-tRNA Synthetases

Nicholas J.H. Warren, Alexander Strom, Brianna Nicolet et al. · The Protein Journal · 2014 · 14 citations

Life Sciences, Biochemistry, Molecular Biology +13

Driving Diversity and Inclusion in Cancer Drug Development – Industry and Regulatory Perspectives, Current Practices, Opportunities, and Challenges

Lola A. Fashoyin‐Aje, Craig Tendler, Bea Lavery et al. · Clinical Cancer Research · 2023 · 14 citations · Full text

Medicine, Oncology, Clinical Pharmacology +16

Differential Sensitivity to CDK2 Inhibition Discriminates the Molecular Mechanisms of CHK1 Inhibitors as Monotherapy or in Combination with the Topoisomerase I Inhibitor SN38

Nicholas J.H. Warren, Katelyn L. Donahue, Alan Eastman · ACS Pharmacology & Translational Science · 2019 · 10 citations · Full text

Life Sciences, Cell Biology, Molecular Biology +17